New Managing Director at Aenova Manufacturing Site Münster
The Aenova site in Münster (Haupt Pharma Münster GmbH) stands out within the group as a competence center for low-dose high-potency solids (hormones and hormone-like oral dosage forms) and dry powder capsules for inhalation devices. With around 250 employees, the Aenova plant in Münster is the market leader in contraceptives and has a long history in the production of hormones, particularly in the area of the contraceptive pill. As of March 15, 2021, Jelmer Dijkstra has been appointed as the new Managing Director of Haupt Pharma Münster GmbH.
Aenova has been able to recruit an experienced General Manager in Jelmer Dijkstra. Jelmer Dijkstra comes from Fresenius Kabi, where he was Site Director in Emmer-Compascuum (NL). Previously, he worked as Plant Manager at Parker Hannifin in Hoogezand and before that in various positions at Siemens Austria in Vienna. Jelmer Dijkstra holds a Master's degree in Mechanical Engineering from Delft University of Technology in the Netherlands.
The Aenova site in Münster has special expertise in the development, production and packaging of tablets and hard gelatin capsules containing highly potent low-dosed active ingredients such as hormones, hormone-related, corticoids, narcotics and other highly potent low-dosed active ingredients. Customers receive all services from a single source: from development to commercial production for OEB levels 1-5. These levels describe the toxicology of a substance. The site's long tradition in the field of contraceptives since 1966 is now complemented by production technologies for micro-dosed capsules, e.g. capsules with dry powder for inhalation. The site is GMP and FDA certified.
"We are delighted to have Jelmer Dijkstra on board, a Managing Director with many years of experience. We wish Mr. Dijkstra every success at Aenova," explains Christine Beck, General Manager and Senior Vice President of the Solida Business Unit at Aenova Group.